Showing results (1-10 of 288) with videos related to
Sort By:
Pageof 29
Trends in Cardiovascular Medicine|July 12, 2011
Characterization of the inflammatory phenotype in atherosclerosis may contribute to the development of new therapeutic and preventative interventionsValentina O Puntmann, Boris Bigalke, Eike NagelEuropean Cardiology|October 13, 2018
Advances in Cardiovascular MRI using Quantitative Tissue Characterisation Techniques: Focus on MyocarditisRocio Hinojar, Eike Nagel, Valentina O PuntmannExpert Review of Cardiovascular Therapy|May 29, 2015
T1 mapping in myocarditis - headway to a new era for cardiovascular magnetic resonanceRocio Hinojar, Eike Nagel, Valentina O PuntmannExpert Review of Cardiovascular Therapy|March 21, 2018
T1 and T2 mapping in myocarditis: seeing beyond the horizon of Lake Louise criteria and histopathologyValentina O Puntmann, Andreas M Zeiher, Eike NagelCirculation Research|July 9, 2016
T1 Mapping in Characterizing Myocardial Disease: A Comprehensive ReviewValentina O Puntmann, Elif Peker, Y Chandrashekhar, et al.European Cardiology|July 3, 2020
Contemporary Cardiac MRI in Chronic Coronary Artery DiseaseMichalis Kolentinis, Melanie Le, Eike Nagel, et al.Expert Review of Cardiovascular Therapy|August 20, 2016
Deciphering cardiac involvement in systemic inflammatory diseases: noninvasive tissue characterisation using cardiac magnetic resonance is key to improved patients' careMartin Gerster, Elif Peker, Eike Nagel, et al.Expert Review of Cardiovascular Therapy|October 29, 2020
COVID-19 myocarditis and prospective heart failure burdenAnastasia Shchendrygina, Eike Nagel, Valentina O Puntmann, et al.Radiology|April 28, 2017
T1 and T2 Mapping in Recognition of Early Cardiac Involvement in Systemic SarcoidosisValentina O Puntmann, Alexander Isted, Rocio Hinojar, et al.Future Cardiology|April 26, 2014
Individualized cardiovascular risk assessment by cardiovascular magnetic resonanceRocio Hinojar, Rene Botnar, Juan Carlos Kaski, et al.Pageof 29